(资料图片仅供参考)
彭博5月15日消息，知情人士称，美国联邦贸易委员会（FTC）预计将于当地时间周二提起诉讼，阻止安进以278亿美元收购生物制药公司地平线治疗（Horizon Therapeutics）的交易，认为这会损害药物开发方面的竞争。
地平线公司开发治疗罕见的自身免疫疾病和严重炎症的药物，总部设在爱尔兰，目前产品主要在美国销售。
(资料图片仅供参考)
彭博5月15日消息，知情人士称，美国联邦贸易委员会（FTC）预计将于当地时间周二提起诉讼，阻止安进以278亿美元收购生物制药公司地平线治疗（Horizon Therapeutics）的交易，认为这会损害药物开发方面的竞争。
地平线公司开发治疗罕见的自身免疫疾病和严重炎症的药物，总部设在爱尔兰，目前产品主要在美国销售。
2023-05-16
2023-05-16
2023-05-16
2023-05-16
2023-05-16
2023-05-16
2023-05-16
2023-05-15
2023-05-15
2023-05-15
2023-05-15
2023-05-15
2023-05-15
2023-05-15
2023-05-15
2023-05-15
2023-05-15
2023-05-15
2023-05-15
2023-05-15
2023-05-15
2023-05-15
2023-05-15
2023-05-15
2023-05-15
2023-05-15
2023-05-15
2023-05-15
2023-05-15
2023-05-15
2023-05-15
2023-05-15
2023-05-15
2023-05-15
2023-05-15
2023-05-15
2023-05-15
2023-05-14
2023-05-14
2023-05-14
2023-05-14
2023-05-14
2023-05-14
2023-05-14
2023-05-14
2023-05-14
2023-05-14
2023-05-14
2023-05-14
2023-05-14
2023-05-14
2023-05-14
2023-05-14
2023-05-14
2023-05-13
2023-05-13
2023-05-13
2023-05-13
2023-05-13
2023-05-13
2023-05-13
2023-05-13
2023-05-13
2023-05-13
2023-05-13
2023-05-13
2023-05-13
2023-05-13
2023-05-13
2023-05-13
2023-05-13
2023-05-13
2023-05-13
2023-05-12
2023-05-12
2023-05-12
2023-05-12
2023-05-12
2023-05-12
2023-05-12
2023-05-12
2023-05-12
2023-05-12
2023-05-12
2023-05-12
2023-05-12
2023-05-12
2023-05-12
2023-05-11
2023-05-11
2023-05-11
2023-05-11
2023-05-11
2023-05-11
2023-05-11
2023-05-11
2023-05-11
2023-05-11
2023-05-11
2023-05-11